Clinical Trials Browser

Phase 2/3 × Breast Neoplasms × CNS × Clear all

NCT01782274 2017-10-12

Proteome-based Immunotherapy of Brain Metastases From Breast Cancer

Phase 2/3 Unknown

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis